Sri Lanka marks war anniversary with many still missing

Agencies
May 18, 2019

Mullaittivu, May 18: Still reeling from the Easter terror attacks, Sri Lanka commemorates this weekend 10 years since the end of a bloody civil war that killed at least 100,000 people, from which the scars are still not healed.

Security was tight in the north of the island, home to Sri Lanka's minority Tamils, ahead of solemn ceremonies on Saturday.

Sri Lanka's government and top military brass were due to hold their own commemoration in Colombo on Sunday.

On May 18, 2009 government forces brought their no-holds-barred military offensive to an end at a lagoon in the northern coastal district of Mullaittivu with the killing of Velupillai Prabhakaran, leader of the rebel Tamil Tigers.

Sri Lanka's then-president Mahinda Rajapakse declared an end to the 37-year separatist conflict -- marked by massacres, suicide bombings and assassinations -- between Tamil militants and the central government, which is dominated by the majority Sinhalese.

But for thousands of war widows and other victims on both sides, this marked the start of a new struggle: to find out the fate of their loved ones.

About 20,000 people are still missing, including 5,000 government troops.

Anandarasan Nagakanni, 61, is still searching for her son Arindavadas.

"He was last seen with the Sri Lankan army, and after that, we haven't seen him," she told AFP at a tiny makeshift office in Mullaittivu, where a notice board was covered with dozens of photos of missing people.

Nagaraja Sureshamma, 65, who lost one son and is still looking for the other, recalled the horrors of the final months and how civilians scrambled to escape indiscriminate attacks and shelling.

"We were all going together, but my son happened to go on a different route... Ever since, we have not been able to find him," Sureshamma said.

"If they are not alive, then they need to tell us that at least," said Mariasuresh Easwari, an activist trying to help find the missing.

"Did you murder them? Did you bury them? Tell us."

Sri Lankan forces have been accused of killing about 40,000 Tamil civilians in the final months of the war, a charge successive governments have denied.

Several mass graves containing skeletal remains have been found in the past two decades, but only a handful of those buried have ever been formally identified.

Until recently, even remembering the war dead was considered subversive and annual memorial services by Tamils were trashed by government forces.

Government forces have set up memorials in the north for fallen security forces and bulldozed Tiger cemeteries, obliterating any sign of the rebels who at their zenith controlled a third of Sri Lanka.

The International Crisis Group (ICG) said in a recent report that the new government's promised political reforms and accountability for wartime atrocities have failed to materialise.

"For many Sri Lankans living in the bitterly contested north and east, the war has never quite ended," it said.

Although the pain for many families remains, and many in the 2.5-million-strong Tamil community still feel disadvantaged, the end of the war did open a peaceful new chapter in which Sri Lanka's economy and tourism boomed.

But this peace was shattered on April 21 when Islamist suicide bombers targeted three churches and three luxury hotels, killing 258 people -- including 45 foreigners.

The attackers were homegrown extremists -- the Islamic State group also claimed credit -- and riots since saw dozens of homes, businesses and mosques of Sri Lanka's Muslim minority vandalised. One man was killed by a mob wielding swords.

According to the ICG, the Easter attacks "compounded the general anxiety, tearing again at the social fabric, unleashing further violence and complicating the road to sustainable peace".

Evoking memories of past dark times, a state of emergency has been in place since April 21 with the return of some wartime restrictions on free movement.

Sri Lanka's army chief Lieutenant General Mahesh Senanayake has said his troops will ensure that this year's commemoration goes ahead peacefully.

"As much as we mourn the soldiers who were killed in the war, (minority Tamil) civilians also have a right to commemorate their war dead," he said on Thursday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 29,2020

Karachi, May 29: Investigators and rescue officials have found around Rs 3 crore in cash in the wreckage of the Pakistan International Airlines' aircraft that crashed wth 99 people on board, killing 97 people, including nine children.

Flight PK-8303 from Lahore to Karachi crashed in a residential area near Karachi International Airport on Friday, with only two passengers miraculously surviving the crash.

Investigators and rescue officials have found currencies of different countries and denominations worth around Rs 30 million from the aircraft's wreckage, an official said on Thursday.

"An investigation has been ordered into how such a huge amount of cash got through airport security and baggage scanners and found its way into the ill-fated flight," the official said.

He said that the amount was recovered from two bags in the wreckage.

"The process of identifying the bodies and their luggage which will be handed over to their families and relatives is going on," he said.

A total of 97 people including the aircraft crew died in the crash, one of the most catastrophic aviation disasters in Pakistan's history.

A government official said on Thursday that the identification of 47 bodies had been completed, while 43 bodies were handed over for burial.

Friday's accident was the first major aircraft crash in Pakistan after December 7, 2016 when a PIA ATR-42 aircraft from Chitral to Islamabad crashed midway. The crash claimed the lives of all 48 passengers and crew, including singer-cum-evangelist Junaid Jamshed.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.